Market Research Industry Today

Ibuprofen API Market Share, Revenue, Price, Growth Rate Ranking Analysis Report 2026-2032

This report systematically analyzes the current status, future trends (2021-2032), and competitive landscape of the global Ibuprofen API market. It provides a quantitative analysis from the perspectives of type (USP、 EP), application (Contract Manufacturing Organizations、 Pharmaceutical Companies、 Others), regional markets, and major manufacturers (IOLCP、 SOLARA、 Shandong Xinhua Pharmaceutical、 Biocause、 BASF、 SI Group), comprehensively assessing market opportunities and competitive dynamics.
Published 26 January 2026

On Jan 26, the latest report "Global Ibuprofen API Market 2026 by Manufacturers, Regions, Types and Applications, Forecast to 2032" from Global Info Research provides a detailed and comprehensive analysis of the global Ibuprofen API market. The report provides both quantitative and qualitative analysis by manufacturers, regions and countries, types and applications. As the market is constantly changing, this report explores market competition, supply and demand trends, and key factors that are causing many market demand changes. The report also provides company profiles and product examples of some of the competitors, as well as market share estimates for some of the leading players in 2026.

Get Report Sample with Industry Insights https://www.globalinforesearch.com/reports/3373917/ibuprofen-api

According to our (Global Info Research) latest study, the global Ibuprofen API market size was valued at US$ 811 million in 2025 and is forecast to a readjusted size of US$ 1150 million by 2032 with a CAGR of 5.2% during review period.



Ibuprofen (API), also known as ibuprofen, is a non-steroidal anti-inflammatory drug for antipyretics and analgesia. It has good anti-inflammatory, analgesic and antipyretic effects. Compared with general anti-inflammatory and analgesic drugs, it has strong effects and few side effects. It has no obvious side effects on the liver, kidneys and hematopoietic system, especially the gastrointestinal tract. At present, ibuprofen has been included in the pharmacopoeias of many countries such as China, the United States, the United Kingdom, Japan, and the European Pharmacopoeia. It has been widely used around the world and has become one of the world's best-selling over-the-counter drugs.

The Ibuprofen API (Active Pharmaceutical Ingredient) market is primarily driven by the increasing global demand for pain relief and anti-inflammatory medications. Ibuprofen is one of the most commonly used nonsteroidal anti-inflammatory drugs (NSAIDs) for treating conditions such as arthritis, fever, headaches, menstrual pain, and other types of mild to moderate pain. The rising prevalence of chronic conditions, such as osteoarthritis and other inflammatory diseases, is driving the demand for Ibuprofen APIs. Additionally, the growing aging population and increasing awareness about over-the-counter (OTC) pain relief medications have contributed to the market's expansion. Manufacturers are also benefiting from the widespread availability of generic Ibuprofen formulations, which have made the drug more accessible and affordable.

However, the market faces challenges related to regulatory scrutiny and competition in the generic drug market. The production of Ibuprofen APIs requires strict compliance with regulatory standards, and companies must invest in quality control to ensure the safety and efficacy of the product. Furthermore, the generic nature of Ibuprofen leads to intense price competition among manufacturers, squeezing profit margins and making it difficult for companies to maintain market share. Another challenge is the rising concern about the side effects of prolonged Ibuprofen use, such as gastrointestinal issues and cardiovascular risks, which may impact consumer confidence and demand in the long term.

Asia-Pacific is the largest market of Ibuprofen API with a share of over 30%, the other two main markets are North America and Europe. The top 3 global manufacturers are IOLCP, Biocause, Shandong Xinhua Pharmaceutical.

This report is a detailed and comprehensive analysis for global Ibuprofen API market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approval.

Ibuprofen API market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type: USP、 EP

Market segment by Application: Contract Manufacturing Organizations、 Pharmaceutical Companies、 Others

Major players covered: IOLCP、 SOLARA、 Shandong Xinhua Pharmaceutical、 Biocause、 BASF、 SI Group

The content of the study subjects, includes a total of 15 chapters:

Chapter 1, to describe Ibuprofen API product scope, market overview, market estimation caveats and base year.

Chapter 2, to profile the top manufacturers of Ibuprofen API, with price, sales quantity, revenue, and global market share of Ibuprofen API from 2021 to 2026.

Chapter 3, the Ibuprofen API competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Ibuprofen API breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.

Chapter 5 and 6, to segment Ibuprofen API the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.

Chapter 7, 8, 9, 10 and 11, to break the Ibuprofen API sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2025.and Ibuprofen API market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2032.

Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.

Chapter 13, the key raw materials and key suppliers, and industry chain of Ibuprofen API.

Chapter 14 and 15, to describe Ibuprofen API sales channel, distributors, customers, research findings and conclusion.

The Primary Objectives in This Report Are:

To determine the size of the total market opportunity of global and key countries

To assess the growth potential for Ibuprofen API

To forecast future growth in each product and end-use market

To assess competitive factors affecting the marketplace

Global Info Research is a company that digs deep into global industry information to support enterprises with market strategies and in-depth market development analysis reports. We provides market information consulting services in the global region to support enterprise strategic planning and official information reporting, and focuses on customized research, management consulting, IPO consulting, industry chain research, database and top industry services. At the same time, Global Info Research is also a report publisher, a customer and an interest-based suppliers, and is trusted by more than 30,000 companies around the world. We will always carry out all aspects of our business with excellent expertise and experience.


Contact Us:

Global Info Research

Web: https://www.globalinforesearch.com

Email: report@globalinforesearch.com

Other Industry News

Ready to start publishing

Sign Up today!